Sources & method. NICE: published technology appraisals; the outcome class (recommended / optimised / not
recommended / terminated) is derived from each guidance page. Classification only:, content
© NICE, linked not reproduced. SMC: published advice
(decision extracted from the public advice text). PBAC: public meeting-outcome documents,
2014 onward (outcome as published; PBAC dates shown as meeting year). HAS (France): SMR/ASMR
ratings from the Base de données publique des médicaments (open licence, attribution required); one row per transparency-committee dossier, best ASMR across presentations). G-BA (Germany): added-benefit
classifications from the machine-readable resolutions under § 35a SGB V (represented accurately
per the G-BA terms of use). Molecules are normalised
from titles for cross-agency grouping and may imperfectly split combination products. Always
consult the linked source before relying on any entry.
Disclaimer. Provided for general information, not medical, regulatory, investment or promotional advice. Decisions summarised here can be superseded by later reviews.
© 2026 Altima Partners Ltd · Company no. 17182962 · sales@altimapartners.co.uk · Privacy · Terms